Transcatheter aortic valve replacement using the Edwards SAPIEN transcatheter heart valves.
Transcatheter aortic valve replacement has a place in the therapy for valvular aortic stenosis in a selected population of patients with increased risk for standard aortic valve replacement. The SAPIEN family of balloon-expandable transcatheter heart valves is the prototype that initiated this therapy and has undergone rapid development and evolution. The SAPIEN system has taught cardiologists and cardiac surgeons much about the nature of aortic stenosis and the potential for less invasive therapy. This article will review the SAPIEN transcatheter heart valves and the clinical experience.
Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Pei-Hsiu
PH
Huang
Andrew C
AC
Eisenhauer
D001024:Aortic Valve Stenosis / Q000628:therapy*; D063126:Balloon Valvuloplasty / Q000379:methods*; D006328:Cardiac Catheterization / Q000379:methods*; D006350:Heart Valve Prosthesis / Q000639:trends*; D019918:Heart Valve Prosthesis Implantation / Q000295:instrumentation* / Q000379:methods / Q000639:trends; D006801:Humans; D011474:Prosthesis Design
Aortic stenosis; Atrioventricular block; Edwards SAPIEN; Paravalvular leak; Transcatheter aortic valve replacement